Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	794	512	481	815	4,056	2,989
Market Cap Growth	86.36%	6.44%	-40.94%	-79.91%	35.71%	103.82%
Enterprise Value	695	354	593	898	3,931	2,924
PE Ratio	-	2.31	-5.26	-2.96	-11.77	-9.66
PS Ratio	2.50	1.79	1.85	3.48	16.10	16.62
PB Ratio	11.06	5.50	-2.62	-4.88	78.68	156.24
P/FCF Ratio	-12.33	-18.73	-11.61	-4.64	-17.06	-12.41
P/OCF Ratio	-12.29	-19.13	-11.72	-4.74	-17.14	-12.42
EV/Sales Ratio	2.19	1.24	2.28	3.84	15.60	16.26
EV/EBITDA Ratio	-13.29	1.44	-20.12	-4.11	-13.35	-10.67
EV/EBIT Ratio	-13.13	1.46	-16.03	-3.96	-12.95	-10.49
EV/FCF Ratio	-10.74	-12.95	-14.31	-5.11	-16.53	-12.14
Debt / Equity Ratio	3.12	3.57	-2.93	-3.36	10.32	19.41
Debt / EBITDA Ratio	-4.41	1.36	-18.31	-2.56	-1.81	-1.35
Debt / FCF Ratio	-3.56	-12.16	-13.02	-3.19	-2.24	-1.54
Quick Ratio	3.92	2.25	2.71	2.90	4.29	4.04
Current Ratio	4.22	2.35	3.02	3.05	4.45	4.22
Asset Turnover	0.66	0.54	0.50	0.38	0.35	0.35
Interest Coverage	-5.02	11.37	-0.68	-4.72	-7.38	-9.13
Return on Equity (ROE)	-82.20%	-164.10%	49.20%	267.70%	-455.80%	-591.20%
Return on Assets (ROA)	-12.70%	41.90%	-17.50%	-44.50%	-48.40%	-59.90%
Return on Capital (ROIC)	-20.75%	-16.02%	-28.22%	-58.35%	-53.53%	-73.13%
Earnings Yield	-7.76%	43.30%	-18.99%	-33.73%	-8.50%	-10.35%
FCF Yield	-7.91%	-5.34%	-8.61%	-21.57%	-5.86%	-8.06%
Buyback Yield / Dilution	-21.87%	-6.09%	3.26%	-4.16%	-11.21%	-13.61%
Total Shareholder Return	-21.87%	-6.09%	3.26%	-4.16%	-11.21%	-13.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).